Cargando…
Exploring the Therapeutic Efficacy of Glioma Vaccines Based on Allo- and Syngeneic Antigens and Distinct Immunological Costimulation Activators
The efficacy of a various immunotherapeutic immunisation strategies for malignant glioma brain cancer was evaluated in the syngeneic CNS-1 Lewis rat glioma model. A prototype glioma cancer vaccine, which was composed of multivalent antigens derived from allogeneic and syngeneic cells and lysates, fo...
Autores principales: | Stathopoulos, Apostolos, Pretto, Chrystel, Devillers, Laurent, Pierre, Denis, Hofman, Florence M., Epstein, Alan L., Farghadani, Hooman, Kruse, Carol A., Jadus, Martin R., Chen, Thomas C., Schijns, Virgil E.J.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062195/ https://www.ncbi.nlm.nih.gov/pubmed/24955288 http://dx.doi.org/10.4172/2155-9899.S5-004 |
Ejemplares similares
-
Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation
por: Stathopoulos, Apostolis, et al.
Publicado: (2012) -
First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity
por: Schijns, Virgil E.J.C., et al.
Publicado: (2015) -
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4(+) T-lymphocyte counts
por: Bota, Daniela A, et al.
Publicado: (2018) -
Therapeutic Immunization against Glioblastoma
por: Schijns, Virgil E. J. C., et al.
Publicado: (2018) -
Immunisation with virion-loaded plasmacytoid or myeloid dendritic cells induces primary Th-1 immune responses
por: Wit, Marel C. de, et al.
Publicado: (2005)